News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Daily News In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition Michael O'Riordan December 11, 2020
News Daily News Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD Michael O'Riordan December 07, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Conference News AHA 2020 Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT Todd Neale November 15, 2020
News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Daily News Coronary Calcium Scans May ID Patients Who Benefit From Aspirin Michael O'Riordan October 30, 2020
News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Daily News Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care Michael O'Riordan October 02, 2020
News Daily News Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors Shelley Wood September 30, 2020
News Daily News Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions Michael O'Riordan September 28, 2020
News Conference News ESC 2020 LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease Caitlin E. Cox August 31, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers Michael O'Riordan August 07, 2020
News Daily News THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA Todd Neale July 16, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020